FindTrial
Sign In

A Prospective Clinical Trial to Evaluate Efficacy of Fourth-generation Autologous Chondrocyte Implantation in Repairing Large-area Cartilage Defects

A Prospective Clinical Trial to Evaluate Efficacy of Fourth-generation Autologous Chondrocyte Implantation in Repairing Large-area Cartilage Defects

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONN-17010886
Enrollment
Unknown
Registered
2017-03-16
Start date
2017-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cartilage Defect

Interventions

Experimental group:ACI surgery
The control group:Micro-fracture surgery

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 55 Years

Inclusion criteria

Inclusion criteria: (1) The cartilage detect area is more than 4cm2; (2) Caused by trauma or osteochondritis dissecans of osteochondritis cartilage defects; (3) 15-55 years of age; (4) Patients are willing to accept and implement a rigorous rehabilitation program; (5) No systemic infection.

Exclusion criteria

Exclusion criteria: (1) Rheumatoid arthritis or inflammatory-related cartilage defects; (2) The body mass index (BMI) higher than 1.5 times the normal amount of obesity; (3) Except for the following: infectious diseases, such as HIV, hepatitis b, hepatitis c, syphilis, etc; (4) Associated with systemic or localized infection

Design outcomes

Primary

MeasureTime frame
IKDC score;—

Countries

China

Contacts

Public ContactZhu Weimin

Shenzhen 2nd People's Hospital

szhzwm@126.com+86 13570879119

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026